AbstractMyostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling is increased by the protein FHL1. Consequently, FHL1 may promote signalling by myostatin. We therefore tested the ability of FHL1 to regulate myostatin function. FHL1 increased the myostatin activity on a SMAD reporter and increased myostatin dependent myotube wasting. In mice, independent expression of myostatin reduced fibre diameter whereas FHL1 increased fibre diameter, both consistent with previously identified effects of these proteins. However, co-expression of FHL1 and myostatin reduced fibre diameter to a greater extent than myostatin alone. Together, these data suggest that the expression of FHL1 may exacerbate muscle wasting under...
Background/Aims Myostatin belongs to the transforming growth factor-beta superfamily and negatively ...
Loss of muscle mass occurs in a variety of diseases, including cancer, chronic heart failure, aquire...
Increasing size and strength of skeletal muscle represents a promising therapeutic strategy for musc...
Myostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling is incr...
AbstractMyostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling...
Myostatin is a negative regulator of skeletal muscle growth and in fact acts as a potent inducer of ...
Myostatin is a transforming growth factor-beta family member that normally acts to limit skeletal mu...
Myostatin, a Transforming Growth Factor-beta (TGF-β) superfamily member, has been well characterised...
Follistatin (FS) inhibits several members of the TGF-β superfamily, including myostatin (Mstn), a ne...
Myostatin was identified more than 20 years ago as a negative regulator of muscle mass in mice and c...
International audienceMyostatin is a member of the TGF beta family which plays a major role in negat...
Muscular dystrophies are characterized by weakness and wasting of skeletal muscle tissues. Several d...
Cachexia is a muscle-wasting syndrome that contributes significantly to morbidity and mortality of m...
Skeletal muscle, the most abundant tissue in the body, plays vital roles in locomotion and metabolis...
Copyright © 2018 Lozier, Kopchick and de Lacalle. Myostatin, a negative regulator of muscle growth, ...
Background/Aims Myostatin belongs to the transforming growth factor-beta superfamily and negatively ...
Loss of muscle mass occurs in a variety of diseases, including cancer, chronic heart failure, aquire...
Increasing size and strength of skeletal muscle represents a promising therapeutic strategy for musc...
Myostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling is incr...
AbstractMyostatin is a TGFβ family ligand that reduces muscle mass. In cancer cells, TGFβ signalling...
Myostatin is a negative regulator of skeletal muscle growth and in fact acts as a potent inducer of ...
Myostatin is a transforming growth factor-beta family member that normally acts to limit skeletal mu...
Myostatin, a Transforming Growth Factor-beta (TGF-β) superfamily member, has been well characterised...
Follistatin (FS) inhibits several members of the TGF-β superfamily, including myostatin (Mstn), a ne...
Myostatin was identified more than 20 years ago as a negative regulator of muscle mass in mice and c...
International audienceMyostatin is a member of the TGF beta family which plays a major role in negat...
Muscular dystrophies are characterized by weakness and wasting of skeletal muscle tissues. Several d...
Cachexia is a muscle-wasting syndrome that contributes significantly to morbidity and mortality of m...
Skeletal muscle, the most abundant tissue in the body, plays vital roles in locomotion and metabolis...
Copyright © 2018 Lozier, Kopchick and de Lacalle. Myostatin, a negative regulator of muscle growth, ...
Background/Aims Myostatin belongs to the transforming growth factor-beta superfamily and negatively ...
Loss of muscle mass occurs in a variety of diseases, including cancer, chronic heart failure, aquire...
Increasing size and strength of skeletal muscle represents a promising therapeutic strategy for musc...